These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33486941)

  • 1. Changes in the allocation policy for deceased donor livers in Korea: perspectives from anesthesiologists.
    Yoo SY; Kim GS
    Anesth Pain Med (Seoul); 2021 Jan; 16(1):68-74. PubMed ID: 33486941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience.
    Park HS; Lee JM; Hong K; Han ES; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS
    Ann Hepatobiliary Pancreat Surg; 2021 Aug; 25(3):336-341. PubMed ID: 34402433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single-center study.
    Lee DH; Park YH; Choi SW; Nam KH; Choi ST; Kim D
    Ann Surg Treat Res; 2021 Dec; 101(6):360-367. PubMed ID: 34934763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation center.
    Ha SM; Hwang S; Song GW; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kim KH; Kim DY; Namgung J; Kang WH; Kim SH; Jwa E; Kwon JH; Cho HD; Jung YK; Kang SH; Lee SG
    Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):199-204. PubMed ID: 29264582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center.
    Ha HS; Hong JJ; Kim IO; Lee SR; Lee AY; Ha TY; Song GW; Jung DH; Park GC; Ahn CS; Moon DB; Kim KH; Lee SG; Hwang S
    Korean J Transplant; 2019 Dec; 33(4):112-117. PubMed ID: 35769978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the MELD-Na and Child-Turcotte-Pugh scores as short-term prognostic indicators of acute-on-chronic hepatitis B liver failure].
    Chen K; Cao X; Zheng Y; Xu M; Peng J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):801-5. PubMed ID: 25531374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Liver Allocation Policy-Consensus Document by the Liver Transplantation Society of India for a Nationally Uniform System of Allocation of Deceased Donor Liver Grafts.
    Reddy MS; Mathur SK; Sudhindran S; Gupta S; Rela M; Soin AS; Mirza D; Asthana S; Chinthakindi M; Jacob M; Kumaran V; Modi P; Mohanka R; Narasimhan G; Pal S; Pamecha V; Rastogi A; Saigal S; Wadhawan M
    J Clin Exp Hepatol; 2023; 13(2):303-318. PubMed ID: 36950486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the allocation system for deceased donor liver transplantation.
    Coombes JM; Trotter JF
    Clin Med Res; 2005 May; 3(2):87-92. PubMed ID: 16012126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is renal replacement therapy necessary in deceased donor liver transplantation candidates with hepatorenal syndrome?: a 2-year experience at a high-volume center.
    Park GC; Hwang S; Jung DH; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Yoon YI; Cho HD; Kwon JH; Chung YK; Kang SH; Jung IJ; Choi JU; Lee SG
    Ann Surg Treat Res; 2020 Feb; 98(2):102-109. PubMed ID: 32051819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J; Lee JG; Jung I; Joo DJ; Kim SI; Kim MS;
    Sci Rep; 2019 May; 9(1):7495. PubMed ID: 31097768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative bacterial infections in deceased donor and living donor liver transplant recipients.
    Varghese J; Gomathy N; Rajashekhar P; Venugopal K; Olithselvan A; Vivekanandan S; Naresh S; Sujatha C; Vijaya S; Jayanthi V; Rela M
    J Clin Exp Hepatol; 2012 Mar; 2(1):35-41. PubMed ID: 25755404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.